AR092939A1 - Vacuna contra cooperia - Google Patents

Vacuna contra cooperia

Info

Publication number
AR092939A1
AR092939A1 ARP130103642A ARP130103642A AR092939A1 AR 092939 A1 AR092939 A1 AR 092939A1 AR P130103642 A ARP130103642 A AR P130103642A AR P130103642 A ARP130103642 A AR P130103642A AR 092939 A1 AR092939 A1 AR 092939A1
Authority
AR
Argentina
Prior art keywords
nucleotide sequences
cooperia
proteins
methods
recombinant dna
Prior art date
Application number
ARP130103642A
Other languages
English (en)
Inventor
Claerebout Edwin
Vercruysse Jozef
Geldhof Peter
Borloo Jimmy
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of AR092939A1 publication Critical patent/AR092939A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Secuencias de nucleótidos que codifican antígenos de Cooperia, así como con moléculas de ADN recombinante que contienen a dichas secuencias de nucleótidos y con células huésped que expresan estas secuencias de nucleótidos. Se relaciona además con proteínas de Cooperia, con métodos para la producción de las proteínas, las secuencias de nucleótidos, moléculas de ADN recombinante y huéspedes. Aún más, se relaciona con vacunas que inducen una inmunidad protectora contra una infección por nematodos parásitos tales como especies del género Cooperia y con métodos para preparar dicha vacuna. Vector, uso, método de vacunación.
ARP130103642A 2012-10-09 2013-10-08 Vacuna contra cooperia AR092939A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12187773 2012-10-09

Publications (1)

Publication Number Publication Date
AR092939A1 true AR092939A1 (es) 2015-05-06

Family

ID=47018872

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103642A AR092939A1 (es) 2012-10-09 2013-10-08 Vacuna contra cooperia

Country Status (7)

Country Link
US (2) US10105424B2 (es)
EP (1) EP2906588B1 (es)
AR (1) AR092939A1 (es)
BR (1) BR112015007678B1 (es)
CA (1) CA2886450C (es)
ES (1) ES2717441T3 (es)
WO (1) WO2014056885A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2886450C (en) * 2012-10-09 2021-10-26 Universiteit Gent Cooperia vaccine
MY202410A (en) 2017-09-01 2024-04-27 Venn Biosciences Corp Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
WO2024089248A1 (en) * 2022-10-27 2024-05-02 Universiteit Gent Recombinant activation-associated secreted protein

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
ES2056565T3 (es) 1990-07-30 1994-10-01 Akzo Nobel Nv Virus recombinante de la enfermedad de marek.
US5525508A (en) 1991-02-06 1996-06-11 Biotech Australia Pty Limited Haemonchus contortus vaccine
US6071518A (en) * 1992-05-29 2000-06-06 The Regents Of The University Of California GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium
US5961970A (en) 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
AU3360797A (en) 1996-07-04 1998-02-02 Universiteit Utrecht Vaccine against gastro-intestinal nematodes
ES2409782T3 (es) 2004-04-05 2013-06-27 Zoetis P Llc Emulsiones de aceite en agua microfluidificadas y composiciones de vacuna
WO2009158729A2 (en) * 2008-06-27 2009-12-30 The Infectious Disease Research Institute Inc. Compounds and methods for diagnosis and treatment of chagas disease
EP2335070B1 (en) 2008-10-08 2017-12-27 Idexx Laboratories, Inc. Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl)
GB0922099D0 (en) * 2009-12-18 2010-02-03 Moredun Res Inst Parasite Vaccine
CA2886450C (en) * 2012-10-09 2021-10-26 Universiteit Gent Cooperia vaccine

Also Published As

Publication number Publication date
US10105424B2 (en) 2018-10-23
US20180369349A1 (en) 2018-12-27
BR112015007678A2 (pt) 2017-08-08
EP2906588A1 (en) 2015-08-19
US20150265687A1 (en) 2015-09-24
US10946077B2 (en) 2021-03-16
WO2014056885A1 (en) 2014-04-17
ES2717441T3 (es) 2019-06-21
CA2886450C (en) 2021-10-26
EP2906588B1 (en) 2018-12-05
BR112015007678B1 (pt) 2022-12-13
CA2886450A1 (en) 2014-04-17

Similar Documents

Publication Publication Date Title
CO2018005265A2 (es) Vacunas de ácido nucleico para el virus varicela-zóster
BR112018008090A2 (pt) vacina de vírus do herpes simplex.
BR112013020070A2 (pt) moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas
BR112017023975A2 (pt) variantes de alfa-amilase e polinucleotídeos codificando as mesmas
MX2018004916A (es) Vacuna contra el virus de la influenza de amplio espectro.
EA201891415A8 (ru) Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения
PE20142406A1 (es) Antigenos asociados a prostata y regimenes de inmunoterapia basados en vacuna
BR112017006736A2 (pt) anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes, e métodos de utilização
EA201591287A1 (ru) Вакцины, содержащие стабилизированные тримеры оболочки вируса иммунодефицита человека, и способы их применения
MX2013014109A (es) Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria.
BR112012030746A2 (pt) cepas hospedeiras fúngigas filamentosas e constructos de dna , e métodos de uso dos mesmos.
MX2018010483A (es) Inmunogenos para vacunacion contra vih.
CO2018012513A2 (es) Anticuerpos
PH12015500308B1 (en) Hepatitis b virus core protein and surface antigen protein and vaccine comprising the same
EA202092990A3 (ru) Молекула нуклеиновой кислоты, кодирующая коровый белок вируса гепатита в, и вакцина, содержащая указанную молекулу
BR112015000585A2 (pt) cepas mutantes de mycoplasma hyopneumoniae
MX2016013631A (es) Celulas huespedes modificadas y usos de las mismas.
MA37749B1 (fr) Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine
PE20160662A1 (es) Anticuerpos especificos para fcrn
UY36617A (es) Proteínas de fusión inmunogénicas para el tratamiento del cáncer
MX2016006758A (es) Composiciones y metodos de vectores para inducir una respuesta inmunitaria mediante el uso de vectores de poxvirus.
MX363149B (es) Vacunas de nucleoproteina de la influenza.
AR092939A1 (es) Vacuna contra cooperia
PH12017501100B1 (en) Recombinant swinepox virus and vaccines
PL406631A1 (pl) Antygen, szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu oraz zastosowanie antygenu określonego powyżej do wytwarzania szczepionki przeciwko grypie